These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 2455187

  • 21. [Efficacy of and tolerance to prolonged release prazosin in patients with hypertension and non-insulin dependent diabetes].
    Hanon O, Giacomino A, Troy S, Bernaud C, Girerd X, Weber S.
    Ann Cardiol Angeiol (Paris); 2000 Oct; 49(7):390-6. PubMed ID: 12555491
    [Abstract] [Full Text] [Related]

  • 22. The effect on HDL cholesterol of oxprenolol and atenolol.
    Kjeldsen SE, Eide I, Leren P, Foss OP, Holme I, Eriksen IL.
    Scand J Clin Lab Invest; 1982 Sep; 42(5):449-53. PubMed ID: 6130595
    [Abstract] [Full Text] [Related]

  • 23. The effect of nifedipine on plasma lipids in patients with essential hypertension.
    Lehtonen A, Tanskanen A, Lehto H, Jarvensiven P.
    Int J Clin Pharmacol Ther Toxicol; 1986 Jul; 24(7):357-8. PubMed ID: 3460970
    [Abstract] [Full Text] [Related]

  • 24. Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects. The GISIR database.
    Bonora E, Capaldo B, Perin PC, Del Prato S, De Mattia G, Frittitta L, Frontoni S, Leonetti F, Luzi L, Marchesini G, Marini MA, Natali A, Paolisso G, Piatti PM, Pujia A, Solini A, Vettor R, Bonadonna RC, Group of Italian Scientists of Insulin Resistance (GISIR).
    Nutr Metab Cardiovasc Dis; 2008 Nov; 18(9):624-31. PubMed ID: 18060751
    [Abstract] [Full Text] [Related]

  • 25. Effect of bucindolol on plasma HDL cholesterol subfractions and other plasma lipids in essential hypertensive patients.
    Lehtonen A, Tanskanen A, Temmerman J.
    Int J Clin Pharmacol Ther Toxicol; 1987 Aug; 25(8):448-51. PubMed ID: 2888737
    [Abstract] [Full Text] [Related]

  • 26. Effects of mefruside treatment in hypertension.
    Henningsen NC, Bergengren B, Malmborg O, Pihl O, Renmarker K, Strand L.
    Acta Med Scand; 1980 Aug; 208(4):272-8. PubMed ID: 7446207
    [Abstract] [Full Text] [Related]

  • 27. [The anti-lipidemic effect of Minipress].
    Pados G, Iványi J, Földes I, Dudás M, Farsang C.
    Orv Hetil; 1990 May 27; 131(21):1139-41. PubMed ID: 2362761
    [Abstract] [Full Text] [Related]

  • 28. [Change in the spectrum of lipids and apoproteins A1 and B as affected by hypothiazide and pratsiol in patients with hypertension].
    Oganov RG, Mustafaev II, Perova NV, Postol'nikov SF, Metel'skaia VA.
    Kardiologiia; 1985 Aug 27; 25(8):17-22. PubMed ID: 4068453
    [Abstract] [Full Text] [Related]

  • 29. Effect of propranolol and prazosin on blood lipids. The Oslo Study.
    Leren P, Foss PO, Helgeland A, Hjermann I, Holme I, Lund-Larsen PG.
    Lancet; 1980 Jul 05; 2(8184):4-6. PubMed ID: 6104255
    [Abstract] [Full Text] [Related]

  • 30. Antihypertensive drugs and blood lipids: the Oslo study.
    Leren P, Eide I, Foss OP, Helgeland A, Hjermann I, Holme I, Kjeldsen SE, Lund-Larsen PG.
    Br J Clin Pharmacol; 1982 Jul 05; 13(Suppl 2):441S-444S. PubMed ID: 7104158
    [Abstract] [Full Text] [Related]

  • 31. Metabolic parameters after changing from hydrochlorothiazide to verapamil treatment in hypertension.
    Lehtonen A, Gordin A.
    Eur J Clin Pharmacol; 1984 Jul 05; 27(2):153-7. PubMed ID: 6389153
    [Abstract] [Full Text] [Related]

  • 32. Initial antihypertensive drug therapy. Final report of a randomized, controlled trial comparing alpha-blocker and diuretic.
    Stamler R, Stamler J, Gosch FC, Berkson DM, Dyer AR, Hershinow P.
    Hypertension; 1988 Dec 05; 12(6):574-81. PubMed ID: 3060429
    [Abstract] [Full Text] [Related]

  • 33. Effect of prazosin on serum lipids.
    Kokubu T, Itoh I, Kurita H, Ochi T, Murata K, Yuba I.
    J Cardiovasc Pharmacol; 1982 Dec 05; 4 Suppl 2():S228-32. PubMed ID: 6177962
    [Abstract] [Full Text] [Related]

  • 34. Effects of prazosin and propranolol on blood lipids and lipoproteins in hypertensive patients.
    Velasco M, Hurt E, Silva H, Urbina-Quintana A, Hernández-Pieretti O, Feldstein E, Camejo G.
    Am J Med; 1986 Feb 14; 80(2A):109-13. PubMed ID: 3080882
    [Abstract] [Full Text] [Related]

  • 35. Changes in the lipoprotein profile during antihypertensive therapy.
    Helgeland A, Leren P, Kjeldsen S, Eide I, Foss OP.
    Acta Pharmacol Toxicol (Copenh); 1984 Feb 14; 54 Suppl 1():75-7. PubMed ID: 6711333
    [Abstract] [Full Text] [Related]

  • 36. Comparison of the effect of indoramin and prazosin on blood pressure and lipid profiles in essential hypertension.
    Overlack A, Stumpe KO.
    J Cardiovasc Pharmacol; 1986 Feb 14; 8 Suppl 2():S53-5. PubMed ID: 2423798
    [Abstract] [Full Text] [Related]

  • 37. Effect of prazosin and beta-blocker monotherapy on serum lipids: a cross-over, placebo-controlled study.
    Magarian EO, Dietz AJ, Freeman DS, Carlson JD.
    J Clin Pharmacol; 1987 Oct 14; 27(10):756-61. PubMed ID: 2892862
    [Abstract] [Full Text] [Related]

  • 38. [Short-term and median-term effects of tienilic acid in hypertension].
    Pirani R, Tomasi AM, Gruppillo P, Masoni A.
    G Ital Cardiol; 1979 Oct 14; 9(12):1345-50. PubMed ID: 549783
    [Abstract] [Full Text] [Related]

  • 39. Platelet activity, prostacycline metabolite, plasma lipids and sympathoadrenal activity in patients with borderline hypertension and a positive family history of hypertension.
    Wocial B, Januszewicz W, Bar-Andziak E, Grzesiuk W, Kuczyńska K, Berent H, Ignatowska-Switalska H, Kapiński M, Młyński J.
    Cor Vasa; 1990 Oct 14; 32(4):265-73. PubMed ID: 2146090
    [Abstract] [Full Text] [Related]

  • 40. Effects of prazosin and alphamethyldopa on blood lipids and lipoproteins in hypertensive patients.
    Velasco M, Silva H, Feldstein E, Pellicer R, Morillo J, Urbina-Quintana A, Hernández-Pieretti O.
    Eur J Clin Pharmacol; 1985 Oct 14; 28(5):513-6. PubMed ID: 3899672
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.